NATHANIEL SCHAEFER: Open Payments
NPI 1992080048 · WHEATON, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,880 in 98 payments from 13 companies in 2025. Trend: 2023 $2,354 · 2024 $1,494 · 2025 $3,880
Food & beverage: $2,655Consulting: $1,125Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 17 | $1,780 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 6 | $372 |
| ABBVIE INC. | 9 | $303 |
| Galderma Laboratories, L.P. | 16 | $256 |
| Regeneron Healthcare Solutions, Inc. | 7 | $198 |
| GENZYME CORPORATION | 7 | $193 |
| Arcutis Biotherapeutics, Inc. | 7 | $168 |
| Novartis Pharmaceuticals Corporation | 9 | $165 |
| Lilly USA, LLC | 6 | $134 |
| UCB, Inc. | 4 | $130 |
Products named: TREMFYA, DUPIXENT, ILUMYA, SKYRIZI, NEMLUVIO, Zoryve, TALTZ, Bimzelx.
Industry payments across IL — which companies pay providers there.
